A detailed history of Smith, Salley & Associates transactions in Danaher Corp stock. As of the latest transaction made, Smith, Salley & Associates holds 887 shares of DHR stock, worth $212,214. This represents 0.02% of its overall portfolio holdings.

Number of Shares
887
Previous 1,293 31.4%
Holding current value
$212,214
Previous $299,000 26.09%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$224.58 - $256.19 $91,179 - $104,013
-406 Reduced 31.4%
887 $221,000
Q4 2023

Jan 24, 2024

BUY
$185.1 - $233.13 $12,957 - $16,319
70 Added 5.72%
1,293 $299,000
Q3 2023

Oct 27, 2023

SELL
$233.08 - $265.59 $3,729 - $4,249
-16 Reduced 1.29%
1,223 $303,000
Q2 2023

Aug 04, 2023

SELL
$224.99 - $256.14 $42,523 - $48,410
-189 Reduced 13.24%
1,239 $297,000
Q1 2023

May 03, 2023

SELL
$239.75 - $277.0 $194,916 - $225,201
-813 Reduced 36.28%
1,428 $359,000
Q4 2022

Feb 03, 2023

SELL
$241.42 - $282.29 $71,218 - $83,275
-295 Reduced 11.63%
2,241 $594,000
Q3 2022

Nov 01, 2022

BUY
$247.06 - $1507.4 $195,671 - $1.19 Million
792 Added 45.41%
2,536 $655,000
Q2 2022

Aug 01, 2022

SELL
$237.11 - $299.66 $106,699 - $134,847
-450 Reduced 20.51%
1,744 $442,000
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $15,950 - $19,577
-62 Reduced 2.75%
2,194 $644,000
Q4 2021

Feb 10, 2022

BUY
$292.08 - $329.01 $20,445 - $23,030
70 Added 3.2%
2,256 $743,000
Q2 2021

Aug 09, 2021

BUY
$225.08 - $271.69 $177,588 - $214,363
789 Added 56.48%
2,186 $586,000
Q1 2021

Apr 30, 2021

BUY
$212.38 - $245.9 $40,564 - $46,966
191 Added 15.84%
1,397 $314,000
Q4 2020

Jan 28, 2021

BUY
$212.5 - $245.46 $256,275 - $296,024
1,206 New
1,206 $268,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $174B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Smith, Salley & Associates Portfolio

Follow Smith, Salley & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.